Gene expression profiling has demonstrated that the activation of angiogenesis is a characteristic feature of MT-HCC, with overexpression of both angiopoietin 2 and vascular endothelial growth factor A (VEGFA) [93]. Here, VEGFA is linked to hepatocellular carcinoma.